chromium(3+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
chromium(3+) — decreases glycated haemoglobin (HbA1c)
Evidence strength: very limited.Findingreplicated ×2“Post-treatment HbA1c values in supplemented patients were significantly lower than those of control patients.”
Quoted verbatim from Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study.. - Study
- RCT
- Duration
- 4 months
- Dose
- 600 μg/day chromium picolinate for four months
- Population
- Patients with poorly controlled type 2 diabetes (HbA1c above 7%) on prescribed medications and ADA nutritional guidance, supplemented with chromium picolinate versus placebo
Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study.2015PMID:2630291410.1016/j.jtemb.2015.05.006Permalink
To cite this finding: https://catalystproject.ai/e/01M5MF8YK5ECAK4NF02XSDHRQ5